Evaluating a diagnostic scale for fibromyalgia in China
Using the Chinese Indigenization FS Scale in the Diagnosis of Fibromyalgia： Specificity and Sensitivity in Clinical Practice
Guang'anmen Hospital of China Academy of Chinese Medical Sciences · NCT06533410
This study is testing a new scale to see how well it can help doctors diagnose fibromyalgia in people with widespread pain in China.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 59 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Guang'anmen Hospital of China Academy of Chinese Medical Sciences (other) |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT06533410 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the specificity and sensitivity of the Chinese Indigenization FS Scale for diagnosing fibromyalgia. By conducting local validation, the study seeks to determine how effectively this scale can identify fibromyalgia in patients with chronic widespread pain. Participants will complete the FM Diagnosis and Assessment Scale, with no additional interventions involved. The findings could enhance diagnostic accuracy for fibromyalgia in clinical practice.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who experience chronic widespread pain and can complete the questionnaire.
Not a fit: Patients with terminal illnesses, severe psychiatric disorders, tumors, systemic lupus erythematosus, systemic sclerosis, or other serious diseases may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the accuracy of fibromyalgia diagnoses, leading to better patient management and treatment outcomes.
How similar studies have performed: While this approach is focused on local validation, similar studies have shown that tailored diagnostic criteria can improve identification of fibromyalgia, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * At least 18 years of age; Patients with chronic widespread pain; Able to complete the questionnaire. Exclusion Criteria: * Terminal patients with severe psychiatric diseases, tumors, systemic lupus erythematosus, systemic sclerosis, or other serious diseases.
Where this trial is running
Beijing, Beijing Municipality
- Guang'anmen Hospital — Beijing, Beijing Municipality, China (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Fibromyalgia